This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chou, T.-C. Articles by Philips, F. S. Search for Related Content PubMed PubMed Citation Articles by Chou, T.-C. Articles by Philips, F. S.

Pharmacological Disposition and Metabolic Fate of 2'-Fluoro-5-iodo-1-ß-D-arabinofuranosylcytosine in Mice and Rats¹

Laboratories of Pharmacology [T.-C. C., A. F., A. J. G., P. V., F. S. P.] and Organic Chemistry [U. R., K. A. W., J. J. F.], Sloan-Kettering Institute for Cancer Research, New York, New York 10021

2'-Fluoro-5-iodo-1-ß-D-arabinofuranosylcytosine (FIAC) is a new potent anti-herpes virus agent which also inhibits the growth of certain human tumor cell lines in vitro. [2-¹⁴C]FIAC has been synthesized for the study of pharmacological disposition and metabolic fate. FIAC is deaminated by cytosine nucleoside deaminase at a rate comparable to that of 1-ß-D-arabinofuranosyl-cytosine. The deaminated product, 2'-fluoro-5-iodo-1-ß-D-arabinofuranosyluracil (FIAU), is, like FIAC, an active antiviral agent. After i.v. injection of [2-¹⁴C]FIAC in mice, most of the radioactivity in plasma appears as FIAU. In i.v.-injected rats which lack cytosine nucleoside deaminase, plasma radioactivity is largely present in unchanged FIAC. If mice are pretreated with tetrahydrouridine, an inhibitor of the nucleoside deaminase, plasma radioactivity is mostly FIAC. The radioactivity of [2-¹⁴C]FIAC injected i.v. is abundantly excreted in urine, at 63 to 93% of the dose in mice and more than 90% of the dose in rats within 0 to 24 hr. Most of the radioactivity in urine of rats and in mice pretreated with tetrahydrouridine is present in unchanged FIAC; in control mice, most of the radioactivity is found in FIAU. Chromatographic analysis of urine from control mice receiving labeled FIAC has revealed that radioactivity is present in the following nucleosides: FIAC (14.5%); FIAU (73%); 2'-fluoro-5-methyl-1-ß-D-arabinofuranosyluracil (5.4%); and 2'-fluoro-1-ß-D-arabinofuranosyluracil (2.3%). These metabolites are also present in acidsoluble fractions of mouse blood, small intestine, and liver. Like FIAC and FIAU, 2'-fluoro-5-methyl-1-ß-D-arabinofuranosyluracil is a potent antiherpetic agent. Only about 4.3% of the radioactivity of injected [2-¹⁴C]FIAC appears in mouse respiratory CO₂; degradation to CO₂ can be blocked by tetrahydrouridine. Less than 2% of the total radioactivity is excreted in bile in rats. Small amounts of radioactivity are also recovered in feces, mostly in deaminated product. FIAC and FIAU, with a 2'-fluoro substituent in the arabino ("up") configuration, appear to be less susceptible to metabolic glycosyl cleavage than is the antiherpetic nucleoside, 5-iodo-2'-deoxyuridine. Finally, the radioactivity of [2-¹⁴C]FIAC is incorporated into DNA fractions of highly proliferating organs such as intestine, spleen, and thymus, although preliminary results indicate that the substances incorporated are arabinofuranosyl nucleoside metabolites of FIAC.

¹ This study was supported in part by National Cancer Institute Grants CA 18856, CA 18601, and CA 08748 and by the Elsa U. Pardee Foundation.

² To whom requests for reprints should be addressed.

Received 1/ 5/81. Accepted 5/20/81.